- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04127149
Evaluation of Ultra-portable Ultrasound in General Practice (EPEMedG)
Pragmatic Evaluation of Ultra-portable Ultrasound for a List of Indications in General Practice
This is an interventional multi-centre study comparing two groups of general practitioners with or without an ultrasound scanner over a period of 6 months. The evaluation focuses on the management of patients for 8 pathologies:
- Pneumonia
- Pleural effusion
- Renal colic
- Hepatic colic or cholecystitis
- Subcutaneous abscess or cyst
- Fracture of long bones
- Intra-uterine pregnancy or extra-uterine pregnancy or miscarriage
- Phlebitis The principal hypothesis is that there are fewer complementary exams in the group of doctors using ultrasound scanners.
The secondary hypotheses are:
- There is better patient orientation (emergency care, specialist consultation, return home) in the group of doctors using the ultrasound scanners.
- The global cost of the care is lower in the group of doctors using the ultrasound.
- Using ultrasound during the consultation decreases the anxiety of the patient.
- Using ultrasound increases the duration of the consultation.
- There is no difference between the predicted and the real orientation of the patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Les Vans, France, 07140
- Maison de santé pluridisciplinaire Léopold Ollier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients age 18 and over
- consulting their general practitioner for one of the 8 conditions below
Exclusion Criteria:
- patients who have already received an imagery exam for the acute episode justifying the consult
- opposition to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group with ultrasound
The first group consists of nine general practitioners having received a brief training on the use of ultrasound scanners in general practice.
The general practitioner includes all adult patients who are consulting for one of the 8 medical conditions studied and perform an ultrasound scan.
Two weeks later, he/she calls each patient to collect the necessary data.
|
The group uses an ultrasound device for the consultation.
|
|
No Intervention: Group without ultrasound
The second group consists of nine general practitioners.
Each physician includes all adult patients who are consulting for one of the 8 medical conditions studied and performs a standard consultation.
Two weeks later, he/she calls each patient to collect the necessary data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of complementary exams
Time Frame: Two weeks after inclusion
|
Two weeks after the initial consultation, with or without ultrasound scanners, the general practitioners call their patients to know:
|
Two weeks after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of hospitalisations, specialist orientation or return home
Time Frame: Two weeks after inclusion
|
Two weeks after the initial consultation, with or without ultrasound scanners, the general practitioners call their patients to know if within the past two weeks, they have been hospitalised, required emergency care, needed to consult a specialist, or returned back home
|
Two weeks after inclusion
|
|
Cost of care
Time Frame: Four weeks after inclusion in the study
|
After knowing the patient orientation and the complementary exams they had, an estimation of the cost of care is made.
|
Four weeks after inclusion in the study
|
|
Anxiety score measured by the State-Trait Anxiety Inventory (STAI-Y) scale
Time Frame: Two weeks after inclusion in the study
|
Two weeks after the initial consultation, with or without ultrasound scanners, the general practitioners call their patients to know the result of the anxiety test they took the day of the first consultation.
|
Two weeks after inclusion in the study
|
|
Consultation duration
Time Frame: Two weeks after inclusion in the study
|
The day of the first consultation, the general practitioner writes the time spent
|
Two weeks after inclusion in the study
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Francis PELLET, MD, Maison de sante pluridisciplinaire Leopold Ollier Les Vans
Publications and helpful links
General Publications
- Dasse-Hartaut J, Couture S. Pragmatic evaluation of handheld point-of-care ultrasound in general practice. MD thesis. Claude Bernard University Lyon 1; 2021. Thesis supervisor: Dr Francis Pellet.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Pain
- Neurologic Manifestations
- Vascular Diseases
- Cardiovascular Diseases
- Neoplasms
- Pathological Conditions, Anatomical
- Female Urogenital Diseases and Pregnancy Complications
- Pregnancy Complications
- Respiratory Tract Infections
- Infections
- Respiratory Tract Diseases
- Digestive System Diseases
- Lung Diseases
- Biliary Tract Diseases
- Peripheral Vascular Diseases
- Gallbladder Diseases
- Vasculitis
- Pleural Diseases
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Abortion, Spontaneous
- Pneumonia
- Pleural Effusion
- Cholecystitis
- Renal Colic
- Cysts
- Pregnancy, Ectopic
- Phlebitis
- Diagnostic Techniques and Procedures
- Diagnosis
- Diagnostic Imaging
- Ultrasonography
Other Study ID Numbers
- 69HCL18_1004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
Clinical Trials on Ultrasound scan
-
Mahidol UniversityCompleted
-
University Hospitals Bristol and Weston NHS Foundation...Bosum Buddies; Friends of the Bristol Haematology and Oncology CentreTerminated
-
ART Fertility Clinics LLCCompletedEndometrial DiseasesUnited Arab Emirates
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast CancersUnited States
-
West China HospitalRecruiting
-
University of MichiganNational Institutes of Health (NIH)CompletedDental Diseases | Bone Loss in JawUnited States
-
University of OxfordCompletedMalignant Pleural EffusionUnited Kingdom
-
University Health Network, TorontoCompletedUltrasound Airway Imaging in Determining the Oral Cavity and Tongue SizeCanada
-
West China HospitalRecruiting
-
Smart Alfa Teknoloji San. ve Tic. A.S.Ankara UniversityCompletedMusculoskeletal Diseases | Ultrasound Imaging of Anatomical StructuresTurkey